Caxton Associates (UK)’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.78M Buy
48,904
+31,646
+183% +$3.91M 0.13% 52
2025
Q4
$2.17M Buy
17,258
+14,417
+507% +$1.88M 0.04% 174
2025
Q3
$416K Buy
2,841
+28
+1% +$4.23K 0.01% 488
2025
Q2
$439K Sell
2,813
-2,834
-50% -$449K 0.01% 461
2025
Q1
$930K Buy
+5,647
New +$939K 0.03% 343

Other funds holding ZTS

Caxton Associates (UK)'s ZTS Position: Q1 2026 in Review

Caxton Associates (UK) increased its Zoetis (ZTS) stake by 183% in Q1 2026, buying an estimated $3.91M and bringing the position to 48,904 shares worth $5.78M. The position accounts for 0.13% of the portfolio, ranked #52.

Caxton Associates (UK) first reported a position in ZTS in Q1 2025 and has held it in 5 quarters since. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Caxton Associates (UK) held 48,904 shares of Zoetis worth $5.78M as of Q1 2026.
  • Caxton Associates (UK) bought 31,646 Zoetis shares in Q1 2026, an estimated $3.91M.
  • Zoetis made up 0.13% of Caxton Associates (UK)'s portfolio in Q1 2026, its #52 holding.
  • Caxton Associates (UK) first reported a position in Zoetis in Q1 2025 and has held it in 5 quarters since.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.